Old Web
English
Sign In
Acemap
>
Paper
>
Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.
Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.
2019
Eric Toussirot
Claude Bernard
Marie Bossert
Keywords:
Diabetes mellitus
Certolizumab
Physical therapy
Dermatology
IL17A
Sarcoidosis
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]